BTN3A1 and systemic lupus erythematosus: Plasma levels of BTN3A1 were significantly increased in SLE patients compared with healthy controls (Figure 1A), and BTN3A1 mRNA expression was significantly increased in SLE patients compared with healthy controls (Figure 1B).